© Cleveland Clinic 2019
For more data like this, visit clevelandclinic.org/hvioutcomes and clevelandclinic.org/e15.
HEART & VASCULAR
Volumes and outcomes from a sampling of centers in Cleveland Clinic’s Miller Family Heart & Vascular Institute
Aortic Valve Replacement
Vitals
Overall Adult Cardiac Surgery
2.0%
operative mortality in latest 12-month period* for all adult surgeries performed (N = 4,704),
including categories for which STS doesn’t rate hospitals or report risk-adjusted benchmarks
50%
share of our cardiac surgery cases that are more complex than those rated by STS
0%
for isolated AVR in latest 12-month period* (N = 356), vs. 1.5% STS predicted rate
1.0%
for AVR + CABG in latest 12-month period* (N = 203), vs. 3.4% STS predicted rate
0.9%
operative mortality in latest 12-month period* for all adult surgery categories reported
to STS (N = 2,347) (no predicted rate available)
SURGICAL AVR OPERATIVE MORTALITY
(AVR)
0.6%
in latest 12-month period*
(N = 462)
TRANSCATHETER AVR PROCEDURAL MORTALITY
*10/1/2017-9/30/2018
STS = Society of Thoracic Surgeons; CABG = coronary artery bypass grafting
Aorta Surgery
3.1%
operative mortality in latest 12-month period* (N = 923) (no predicted rate available)
1.4%
operative mortality for elective cases in latest 12-month period*
(N = 628)
Isolated Mitral Valve Repair
0%
operative mortality over the past 5 years (2014 through end of 2018)
(N = 1,805), vs. 0.6% STS predicted rate
*10/1/2017-9/30/2018
~
~
%
*10/1/2017-9/30/2018